US$ 27.37
glp 1 and high triglycerides Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty liver disease? Major physiological roles of GLP-1
Description
Many who had reached normal blood sugar levels during the intervention reverted back to prediabetic ranges, highlighting that the benefits often fade once the medication is discontinued
Best For Recommendations# Maximum Weight Loss# Recommendation : Retatrutide Reason : Phase 3 TRIUMPH-4 showed 28.7% weight loss at 68 weeks, substantially exceeding CagriSema's 20.4% at 68 weeks

(source) A 2017 meta-analysis did not support the suggestion that treatment with GLP-1 agonists or DPP-4 inhibitors increased all-cause mortality in type 2 diabetics

Several studies have reported early worsening following semaglutide treatment, although the underlying mechanism remains unclear [11,12,13,14]
